Epidemiology studies indicate that Alzheimer’s disease(AD) is substantially preventable in the United States. Fifty percent reduction in incidence appears within reach of public health programs,with seventy percent reduction also feasible with greater participation of the public.
In contrast,therapeutic opportunities for un-prevented AD are limited to the slowing of progression by three to eleven months due to extensive death of brain cells before diagnosis is made.